Company intelligence / Profile preview

MZR Neurotech

Berkeley, California, United States

Ownership: Private
Development stage: Other

Overview

MZR Neurotech has developed an in‑ear electroencephalogram (EEG) sensor packed with biosensors to measure sleep patterns and brain activity, enabling at‑home, sleep‑clinic–grade assessment and screening for sleep and cognitive disorders; it is positioned as a hardware + AI software platform rather than a drug or traditional clinical‑trial pipeline.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Beyond the preview

Go deeper on MZR Neurotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MZR Neurotech.

Explore the full profile